Parkinsonism belongs to the most common neurodegenerative disease. Genetic predisposition could be one of the significant risk factor for disease development. It has been described higher prevalence of parkinsonism in large pedigree from southeastern Moravia region. The study aims were to select accessible subfamily trios from the pedigree suitable for segregation genetic analyses to perform whole exome sequencing (WES) in trio individuals and further to evaluate genetic variants in the each trio. We used IonTorrent platform for WES for five subfamily trios (1-5). Each trio included two affected and one healthy person (as control). Found variants were filtered with respect to MAF < 1% (minor allele frequency), variants effect (based on prediction tools) and disease filter (Parkinsonism responsible genes). Finally, the variants from each trio were assessed with respect to the presence in the patients. There were found no one founder mutation in the subfamilies from the pedigree. Trio 1 shares two variants with trio 2:MC1R:c.322G > A (p.A108T) and MTCL1:c.1445C > T (p.A482V), trio 3 shares two variants with trio 5: DNAJC6:c.1817A > C (p.H606P) and HIVEP3:c.3856C > A (p.R1286W). In trios 4 and 5, there were found two variants in gene CSMD1:c.3335A > G (p.E1112G) and c.4071C > G (p.I1357M) respectively. As the most potentially damaging, we evaluated the non-shared variant SLC18A2:c.583G > A (p.G195S). The variant could affect dopamine transport in dopaminergic neurons. The study of the parkinsonism genetic background in isolated Moravian population suggested that there could be significant accumulation of many risk genetic factors. For verification of the variants influence, it would be appropriate to perform a more extensive population study and suitable functional analysis.

Department of Medical Genetics Faculty of Medicine and Dentistry Palacký University Olomouc Olomouc Czechia

Department of Medical Genetics University Hospital Olomouc Olomouc Czechia

Department of Neurology Faculty of Medicine and Dentistry Palacký University Olomouc Olomouc Czechia

Department of Neurology University Hospital Olomouc Olomouc Czechia

Zobrazit více v PubMed

Allen C. E., Mak C. H., Wu L. C. (2002). The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study. PubMed DOI PMC

Ando M., Fiesel F. C., Hudec R., Caulfield T. R., Ogaki K., Górka-Skoczylas P., et al. (2017). The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity. PubMed DOI PMC

Bandres-Ciga S., Diez-Fairen M., Kim J. J., Singleton A. B. (2020). Genetics of Parkinson’s disease: an introspection of its journey towards precision medicine. PubMed DOI PMC

Brighina L., Riva C., Bertola F., Saracchi E., Fermi S., Goldwurm S., et al. (2013). Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease. PubMed DOI PMC

Buervenich S., Carmine A., Galter D., Shahabi H. N., Johnels B., Holmberg B., et al. (2005). A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. PubMed DOI

Campêlo C. L. C., Cagni F. C., de Siqueira Figueredo D., Oliveira L. G., Jr., Silva-Neto A. B., Macêdo P. T., et al. (2017). Variants in SNCA gene are associated with parkinson’s disease risk and cognitive symptoms in a brazilian sample. PubMed DOI PMC

Chartier-Harlin M. C., Dachsel J. C., Vilariño-Güell C., Lincoln S. J., Leprêtre F., Hulihan M. M., et al. (2011). Translation initiator EIF4G1 mutations in familial Parkinson disease. PubMed DOI PMC

Dolgacheva L. P., Berezhnov A. V., Fedotova E. I., Zinchenko V. P., Abramov A. Y. (2019). Role of DJ-1 in the mechanism of pathogenesis of Parkinson’s disease. PubMed DOI PMC

Edvardson S., Cinnamon Y., Ta-Shma A., Shaag A., Yim Y. I., Zenvirt S., et al. (2012). A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PubMed DOI PMC

Farlow J. L., Robak L. A., Hetrick K., Bowling K., Boerwinkle E., Coban-Akdemir Z. H., et al. (2016). Whole-Exome sequencing in familial parkinson disease. PubMed DOI PMC

Gan-Or Z., Mohsin N., Girard S. L., Montplaisir J. Y., Ambalavanan A., Strong S., et al. (2016). The role of the melanoma gene MC1R in Parkinson disease and REM sleep Behavior Disorder. PubMed DOI PMC

Gao X., Simon K. C., Han J., Schwarzschild M. A., Ascherio A. (2009). Genetic determinants of hair color and Parkinson’s disease risk. PubMed DOI PMC

Gazal S., Gosset S., Verdura E., Bergametti F., Guey S., Babron M. C., et al. (2016). Can whole-exome sequencing data be used for linkage analysis? PubMed DOI PMC

Guo J. F., Zhang L., Li K., Mei J. P., Xue J., Chen J., et al. (2018). Coding mutations in NUS1 contribute to Parkinson’s disease. PubMed DOI PMC

Håvik B., Le Hellard S., Rietschel M., Lybæk H., Djurovic S., Mattheisen M., et al. (2011). The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. PubMed DOI

Hughes A. J., Daniel S. E., Ben-Shlomo Y., Lees A. J. (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. PubMed DOI

Kalinderi K., Bostantjopoulou S., Fidani L. (2016). The genetic background of Parkinson’s disease: current progress and future prospects. PubMed DOI

Köroğlu Ç, Baysal L., Cetinkaya M., Karasoy H., Tolun A. (2013). DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. PubMed DOI

Kraus D. M., Elliott G. S., Chute H., Horan T., Pfenninger K. H., Sanford S. D., et al. (2006). CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. PubMed DOI

Lin G., Lee P. T., Chen K., Mao D., Tan K. L., Zuo Z., et al. (2018). Phospholipase PLA2G6, a parkinsonism-associated gene, affects Vps26 and Vps35, retromer function, and ceramide levels, similar to α-Synuclein gain. PubMed DOI

Liu Y., Edwards R. H. (1997). The role of vesicular transport proteins in synaptic transmission and neural degeneration. PubMed DOI

Lopez O. L., Smith G., Meltzer C. C., Becker J. T. (1999). Dopamine systems in human immunodeficiency virus-associated dementia. PubMed

Marti T., Puig-Butille J. A., Potrony M., Badenas C., Milà M., Malvehy J., et al. (2015). The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. PubMed DOI

Mensikova K., Kanovsky P., Kaiserova M., Mikulicova L., Vastik M., Hlustik P., et al. (2013). Prevalence of neurodegenerative parkinsonism in an isolated population in south-eastern moravia, czech republic. PubMed DOI

Mensikova K., Kaňovský P., Otruba P., Kaiserová M., Vastik M., Hlustik P., et al. (2014). Epidemiological study of neurodegenerative Parkinsonism in “Hornacko”, a specific region of the south-eastern moravia, czech republic. DOI

Miller S. A., Dykes D. D., Polesky H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. PubMed DOI PMC

Mir R., Tonelli F., Lis P., Macartney T., Polinski N. K., Martinez T. N., et al. (2018). The Parkinson’s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. PubMed DOI PMC

Mosharov E. V., Larsen K. E., Kanter E., Phillips K. A., Wilson K., Schmitz Y., et al. (2009). Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. PubMed DOI PMC

Ortega R. A., Wang C., Raymond D., Bryant N., Scherzer C. R., Thaler A., et al. (2021). Association of dual LRRK2 G2019S and GBA variations with parkinson disease progression. PubMed DOI PMC

Park J. S., Blair N. F., Sue C. M. (2015). The role of ATP13A2 in Parkinson’s disease: clinical phenotypes and molecular mechanisms. PubMed DOI

Ruiz-Martínez J., Azcona L. J., Bergareche A., Martí-Massó J. F., Paisán-Ruiz C. (2017). Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease. PubMed DOI PMC

Sato Y., Akitsu M., Amano Y., Yamashita K., Ide M., Shimada K., et al. (2013). The novel PAR-1-binding protein MTCL1 has crucial roles in organizing microtubules in polarizing epithelial cells. PubMed DOI

Schwalbe M., Biernat J., Bibow S., Ozenne V., Jensen M. R., Kadavath H., et al. (2013). Phosphorylation of human Tau protein by microtubule affinity-regulating kinase 2. PubMed DOI

Thiriot D. S., Sievert M. K., Ruoho A. E. (2002). Identification of human vesicle monoamine transporter (VMAT2) lumenal cysteines that form an intramolecular disulfide bond. PubMed DOI

Toma C., Díaz-Gay M., Franch-Expósito S., Arnau-Collell C., Overs B., Muñoz J., et al. (2020). Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer. PubMed DOI PMC

Vodicka R., Kolarikova K., Vrtel R., Mensikova K., Kanovsky P., Prochazka M. (2020). “Evaluating basic next-generation sequencing parameters in relation to true/false positivity findings of rare variants in an isolated population from the Czech Republic South-Eastern Moravia Region with a high incidence of parkinsonism,” in DOI

Xiromerisiou G., Bourinaris T., Houlden H., Lewis P. A., Senkevich K., Hammer M., et al. (2021). SORL1 mutation in a Greek family with Parkinson’s disease, and dementia. PubMed DOI PMC

Yemni E. A., Monies D., Alkhairallah T., Bohlega S., Abouelhoda M., Magrashi A., et al. (2019). Integrated analysis of whole exome sequencing and copy number evaluation in Parkinson’s Disease. PubMed DOI PMC

Yi W., MacDougall E. J., Tang M. Y., Krahn A. I., Gan-Or Z., Trempe J. F., et al. (2019). The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson’s disease. PubMed DOI PMC

Yim Y. I., Sun T., Wu L. G., Raimondi A., De Camilli P., Eisenberg E., et al. (2010). Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice. PubMed DOI PMC

Endemic parkinsonism: clusters, biology and clinical features